Saturday, September 19, 2020 3:12:11 PM
Of the 100 best selling drugs, nearly 80 percent have extended their patents at least once, and 50 percent have extended their patents multiple times to block generic competition and maintain their stranglehold on critical medications.>>>>>>>>>>>>>>>>>>>
In fact, a recent series of studies conducted by Initiative for Medicines, Access, and Knowledge (I-MAK) found that of the top 12 grossing drugs in America, over 125 patent applications were filed and 71 were granted per drug. These patent applications attempted to block generic competition from entering the market by an average of 38 years, nearly double 20-year protection normally intended under U.S. patent laws. https://www.csrxp.org/the-truth-about-big-pharmas-patent-abuse/
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM